- Home
- ANIX vs LRE Comparison
ANIX vs LRE Comparison
Compare ANIX & LRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ANIX | LRE |
|---|---|---|
| Founded | 1982 | 2001 |
| Country | United States | Japan |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 135.3M | 20.5M |
| IPO Year | 1987 | 2023 |
Fundamental Metrics
Financial Performance| Metric | ANIX | LRE |
|---|---|---|
| Price | $3.39 | $1.34 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $9.00 | N/A |
| AVG Volume (30 Days) | ★ 442.6K | 7.3K |
| Earning Date | 01-09-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 32.27 |
| EPS | N/A | ★ 0.43 |
| Revenue | N/A | ★ $130,601,512.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $3.11 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.07 | $1.00 |
| 52 Week High | $5.46 | $2.97 |
Technical Indicators
Market Signals| Indicator | ANIX | LRE |
|---|---|---|
| Relative Strength Index (RSI) | 38.17 | 47.73 |
| Support Level | $3.18 | $1.25 |
| Resistance Level | $3.64 | $1.45 |
| Average True Range (ATR) | 0.43 | 0.06 |
| MACD | -0.17 | 0.01 |
| Stochastic Oscillator | 8.35 | 45.20 |
Price Performance
Historical ComparisonAbout ANIX Anixa Biosciences Inc.
Anixa Biosciences Inc a cancer-focused biotechnology company, develops vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.
About LRE Lead Real Estate Co. Ltd
Lead Real Estate Co Ltd operates as a developer of luxury residential properties, including single-family homes and condominiums, across Tokyo, Kanagawa prefecture, and Sapporo. The company also operates hotels in Tokyo and leases apartment building units to individual customers in Japan and Dallas, Texas. Predominantly, its revenue is generated from developing and selling single-family homes and condominiums. The company's sole operating segment is real estate sales. Geographically, it derives revenue from Japan.